No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study

SUMMARY: This study was performed to evaluate whether the use of drugs in the treatment of osteoporosis in women is associated with COVID-19 outcomes. The results showed that the risk of hospitalization, intensive care unit admission, and mortality was not altered in individuals taking anti-osteopor...

Descripción completa

Detalles Bibliográficos
Autores principales: Atmaca, A., Demirci, I., Haymana, C., Tasci, I., Sahin, I., Cakal, E., Ata, N., Dagdelen, S., Salman, S., Emral, R., Sahin, M., Celik, O., Demir, T., Ertugrul, D., Unluturk, U., Caglayan, M., Satman, I., Sonmez, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369875/
https://www.ncbi.nlm.nih.gov/pubmed/34402949
http://dx.doi.org/10.1007/s00198-021-06067-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369875/
https://www.ncbi.nlm.nih.gov/pubmed/34402949
http://dx.doi.org/10.1007/s00198-021-06067-2

Ejemplares similares